Getting ready for full implementation of the EU Clinical Trial Regulation The countdown is on for the European Union (EU) Clinical Trial Regulation (Regulation (EU) No 536/2014) (CTR) with a go-live date of 31 January 2022. The implementation of the CTR will bring about significant changes to the way clinical trials are conducted in the EU. In this article Cromos Pharma considers some of the requirements for sponsors. The
Cromos Pharma supporting psoriasis clinical research breakthroughs August is Psoriasis Awareness Month. Cromos Pharma is using this opportunity to underline its commitment to supporting clinical trials to develop new and innovative treatments to improve the lives of millions of psoriasis sufferers around the world. Immune disorder affecting 125 million people worldwide Psoriasis is a complex immune system disorder in which white blood cells,
Reaping the benefits of eCONSENT for clinical trials Clinical research is made possible because patient volunteers give their consent to participate in clinical trials. Informed consent is an essential part of enrolling patients in a clinical trial. Through the consent process a potential participant receives all the information they need about their role in the clinical trial. eCONSENT While in the past consent was acquired
